Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 301012 in Homozygous Familial Hypercholesterolemia
NCT00280995Phase 2Completed
- Sponsor
- Kastle Therapeutics LLC
- Start
- Jan 2006
- Primary completion
- Apr 2007
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 2
01
Overview
A Phase 2 trial of mipomersen in homozygous familial hypercholesterolemia (HoFH), sponsored by Kastle Therapeutics LLC. Started Jan 2006; status: completed.
02
Drugs
mipomersen
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT00280995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280995.